Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to 0.14%.

  • Krystal Biotech's Return on Capital Employed rose 1100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.08% for FY2024, which is 2500.0% up from last year.
  • As of Q3 2025, Krystal Biotech's Return on Capital Employed stood at 0.14%, which was up 1100.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Return on Capital Employed registered a high of 0.14% during Q3 2025, and its lowest value of 0.28% during Q1 2023.
  • In the last 5 years, Krystal Biotech's Return on Capital Employed had a median value of 0.14% in 2023 and averaged 0.1%.
  • As far as peak fluctuations go, Krystal Biotech's Return on Capital Employed tumbled by -1400bps in 2022, and later surged by 2400bps in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Return on Capital Employed stood at 0.13% in 2021, then plummeted by -103bps to 0.27% in 2022, then surged by 47bps to 0.14% in 2023, then surged by 150bps to 0.07% in 2024, then soared by 101bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.14% for Q2 2025, and 0.11% during Q1 2025.